Literature DB >> 10913911

Anabolic effects of basic fibroblast growth factor in the tibial diaphysis of ovariectomized rats.

S Pun1, C L Florio, T J Wronski.   

Abstract

The purpose of this study was to determine the effects of basic fibroblast growth factor (bFGF) on cortical bone in ovariectomized (ovx) rats. Female Sprague-Dawley rats were subjected to sham surgery or ovariectomy at 3 months of age and maintained untreated for 2 months after surgery. Polyurethane catheters were then inserted in the jugular veins of all rats for daily intravenous treatments with vehicle or bFGF at doses of 100 or 200 microg/kg for 7 or 14 days. Other groups of ovx rats were killed at 7 or 14 days after withdrawal of treatment with the higher dose of bFGF. Quantitative bone histomorphometry was performed in undecalcified cross sections of the tibial diaphysis. Cortical bone area was nearly the same in vehicle-treated control and ovx rats, but a small, statistically significant increase in this structural variable was observed in ovx rats treated with both doses of bFGF. This small increase in cortical bone area was maintained at 7 days after withdrawal of bFGF treatment. Fluorochrome-based analyses of periosteal and endocortical bone formation were inconclusive due to an inhibitory effect of bFGF on bone mineralization. However, a marked increase in fluorescent bone area was observed within the marrow cavity of bFGF-treated OVX rats during the withdrawal period. The results indicate that treatment of OVX rats with bFGF for only 7 to 14 days augments cortical bone mass and induces formation of bone spicules within the marrow cavity of the tibial diaphysis. These bone anabolic effects of the growth factor support its consideration as a potential osteoporosis therapy.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2000        PMID: 10913911     DOI: 10.1016/s8756-3282(00)00312-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

1.  Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.

Authors:  Wei Yao; Tamer Hadi; Yebin Jiang; Jeff Lotz; Thomas J Wronski; Nancy E Lane
Journal:  Osteoporos Int       Date:  2005-08-05       Impact factor: 4.507

2.  Induction of an osteocyte-like phenotype by fibroblast growth factor-2.

Authors:  Rishi R Gupta; David J Yoo; Carla Hebert; Corinne Niger; Joseph P Stains
Journal:  Biochem Biophys Res Commun       Date:  2010-10-08       Impact factor: 3.575

3.  Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model.

Authors:  N E Lane; J Kumer; W Yao; T Breunig; T Wronski; G Modin; J H Kinney
Journal:  Osteoporos Int       Date:  2003-05-24       Impact factor: 4.507

Review 4.  Gene therapy approaches for bone regeneration.

Authors:  Renny T Franceschi; Shuying Yang; R Bruce Rutherford; Paul H Krebsbach; Ming Zhao; Dian Wang
Journal:  Cells Tissues Organs       Date:  2004       Impact factor: 2.481

5.  Long-term Observation of Regenerated Periodontium Induced by FGF-2 in the Beagle Dog 2-Wall Periodontal Defect Model.

Authors:  Jun Anzai; Toshie Nagayasu-Tanaka; Akio Terashima; Taiji Asano; Satoru Yamada; Takenori Nozaki; Masahiro Kitamura; Shinya Murakami
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 6.  A review of anabolic therapies for osteoporosis.

Authors:  Nancy E Lane; Ariella Kelman
Journal:  Arthritis Res Ther       Date:  2003-08-05       Impact factor: 5.156

Review 7.  Concepts of scaffold-based tissue engineering--the rationale to use solid free-form fabrication techniques.

Authors:  D W Hutmacher; S Cool
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

8.  Opposing effects of Sca-1(+) cell-based systemic FGF2 gene transfer strategy on lumbar versus caudal vertebrae in the mouse.

Authors:  K-H W Lau; S-T Chen; X Wang; S Mohan; J E Wergedal; C Kesavan; A K Srivastava; D S Gridley; S L Hall
Journal:  Gene Ther       Date:  2016-03-02       Impact factor: 4.184

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.